1. Introduction {#sec1}
===============

Isolated adrenocorticotropic hormone (ACTH) deficiency causes secondary hypocortisolism. Major symptoms, which include general malaise, fatigability, anorexia, hypotension, and disturbance of consciousness, are due to hypoglycemia or hyponatremia. Isolated ACTH deficiency is suspected when hypocortisolism is present in addition to the major symptoms already listed. A definite diagnosis requires low or absent serum ACTH or cortisol levels under corticotropin-releasing hormone (CRH) challenge. Although depression-like symptoms are common in hypocortisolism \[[@B1]\], only three cases of delirium with isolated ACTH deficiency have been reported \[[@B2]--[@B4]\]. In addition, there were some reports of ACTH deficiency associated with Takotsubo cardiomyopathy \[[@B5]--[@B9]\], which is characterized by transient left ventricular apical wall motion abnormality with electrocardiographic changes and minimal myocardial enzymatic release mimicking acute myocardial infarction, but without significant coronary artery disease \[[@B10]--[@B15]\].

Here, we report a case of delirium and Takotsubo cardiomyopathy during acute adrenal crisis due to isolated ACTH deficiency.

2. Case Report {#sec2}
==============

A 65-year-old woman was admitted to our hospital, complaining of malaise and nausea of one-week duration without preceding infection. She had been in good health until that time except for suffering from Hashimoto\'s disease, which was treated with thyroid hormone, levothyroxine 75 *μ*g/day in another hospital and was well controlled. She was nulligravida and menopausal at 60 years old. In addition, she had no psychiatric history.

On admission, her body temperature was 35.6°C, blood pressure 157/94 mmHg, and pulse rate 75/min. She exhibited obtundation and her Glasgow Coma Scale was 14 (E4V4M6). Physical examination showed no abnormalities. Her skin and mucosa were free of unusual pigmentation and there were no lack of physiological pigmentation and body hair. Laboratory findings showed only low serum levels of sodium (116 mEq/L, [Table 1](#tab1){ref-type="table"}). On electrocardiogram (ECG), T waves were inverted in leads II, III, V1, and V2 as minor abnormalities ([Figure 1](#fig1){ref-type="fig"}).

After admission, her consciousness levels were improved for alertness and we tried to treat the hyponatremia by intravenous infusion. However, four days after admission, she presented with paranoia and visual hallucinations. She said, for example, "I was arrested in the hospital," "The pattern on the walls began to spin," and "Grass is growing on the window panes." She was delirious. We consulted psychiatrists who prescribed quetiapine for her delirium. Furthermore, on the same day, she complained of nausea and was pale and sweating. Her blood pressure was 63/48 mmHg, body temperature was 36.0°C, and her SpO~2~ index was unstable (70--90%). She was thought to be in a state of acute circulatory failure. Because the electrocardiogram showed new inverted T waves in leads V2-5 ([Figure 1](#fig1){ref-type="fig"}), urgent coronary catherization was performed for possible percutaneous intervention. However, coronary angiography demonstrated no significant coronary stenosis. Left ventriculography showed akinesis of the left ventricular apex with ballooning during systole ([Figure 2](#fig2){ref-type="fig"}). Blood examination revealed neither significant hypoglycemia nor electrolyte abnormalities other than hyponatremia (118 mEq/L). The serum levels of creatinine kinase (CK) (603 IU/L), CK-MB (24 IU/L), and troponin I (6.80 ng/mL) were slightly elevated. These findings are consistent with Takotsubo cardiomyopathy.

Considering her status of hyponatremia, delirium, and Takotsubo cardiomyopathy, we supposed she could be suffering an acute adrenal crisis and started intravenous administration of 400 mg/day hydrocortisone. On the following day, we confirmed decreased cortisol (2.2 *μ*g/dL, [Table 2(a)](#tab2){ref-type="table"}) and ACTH (8.4 pg/mL) levels and began oral administration of 20 mg/day hydrocortisone. Following the administration of hydrocortisone, the hyponatremia and delirium improved dramatically in 3 days. Her sodium level reached 139 mEq/L and her consciousness level became alert. An echocardiogram showed the left ventricular wall motion abnormalities including apical segment to be also markedly improved by 10 days after steroid administration.

Endocrine studies showed decreases in serum cortisol and ACTH and reduced urinary secretion of free cortisol. The plasma cortisol level responded slightly after a bolus injection of 0.25 mg ACTH ([Table 2(b)](#tab2){ref-type="table"}). In addition, continuous ACTH-Z stimulation (0.5 mg injected daily for 4 days) produced a gradual but clear increase in the urinary excretion of free cortisol ([Table 2(d)](#tab2){ref-type="table"}). Treatment with ACTH-releasing hormone did not increase the plasma ACTH concentration ([Table 2(c)](#tab2){ref-type="table"}). On the other hand, growth hormone (GH) levels were increased by GH-releasing hormone ([Table 2(c)](#tab2){ref-type="table"}). Although the luteinizing hormone (LH) and follicle stimulating hormone (FSH) levels were slightly increased by LH-releasing hormone, their basal levels were high enough because of her postmenopausal state, and we consider that LH- and FSH-releasing ability was unimpaired ([Table 2(c)](#tab2){ref-type="table"}). We did not perform an infusing TSH-releasing hormone test. Because she was under treatment for Hashimoto\'s disease involving levothyroxine intake and euthyroid upon admission ([Table 2(a)](#tab2){ref-type="table"}), her hypothalamus function with respect to TSH-releasing ability should not have been impaired. We also did not perform an insulin tolerance test (ITT) because she was elderly and the possibility of severe cardiac involvement was present. Plasma renin activity and plasma aldosterone concentration were normal ([Table 2(a)](#tab2){ref-type="table"}). Therefore, the diagnosis of isolated ACTH deficiency was made. Magnetic resonance imaging (MRI) revealed no pituitary lesions or adjacent lesions.

3. Discussion {#sec3}
=============

Adrenal insufficiency was conclusively diagnosed following endocrinological examination based on the markedly decreased plasma cortisol level. The ACTH level was low while the remaining pituitary functions were normal, which led to the diagnosis of isolated ACTH deficiency. Although our patient complained of malaise and nausea for a week prior to admission, the plasma cortisol level responded slightly (\<18 *μ*g/mL) after a bolus injection of 0.25 mg ACTH ([Table 2(b)](#tab2){ref-type="table"}). It was considered that she had suffered secondary insufficiency for more than a week.

Three cases of delirium concurrent with isolated ACTH deficiency have been reported \[[@B2]--[@B4]\] ([Table 3](#tab3){ref-type="table"}). Administration of hydrocortisone dramatically improved consciousness in all cases including ours, and this immediate improvement suggests significant links between delirium and adrenal insufficiency. Interestingly, the patient in our case showed paranoid thinking and visual hallucinations. In the previous reports, the patients showed symptoms that included incoherent speech, disorientation, and incontinence \[[@B2]--[@B4]\]. We believe our case is the first to describe delirium concurrent with isolated ACTH deficiency, presenting paranoid thinking and visual hallucinations. Considering all reports \[[@B2]--[@B4]\] ([Table 3](#tab3){ref-type="table"}), most cases developed delirium with preceding unresolved gastrointestinal symptoms in accordance with hyponatremia in geriatric patients. In addition, they did not have any special psychiatric history. Facing delirium patients having these situations, clinicians should pay attention to adrenal insufficiency as a cause of delirium.

Takotsubo cardiomyopathy is now an established syndrome worldwide \[[@B16]--[@B19]\], but there are no universally accepted diagnostic criteria for this syndrome. Major clinical characteristics are as follows. First, the symptoms are similar to those of acute myocardial infarction. Second, most cases involve elderly woman. Third, Takotsubo-like left ventricular dysfunction, which extends over more than one coronary artery region, is transient and resolves within several weeks. These findings are consistent with our case. Furthermore, myocardial damage is usually excluded when the CK-MB is \<5 or 6% of the total CK activity; in our case, the CK-MB was 4.1% of the total CK activity. The CK elevation may result not from myocardial damage, but rather from the skeletal muscle. Pheochromocytoma can cause myocardial damage unrelated to the coronary arteries \[[@B20]\]. Therefore, although we measured the plasma and urine catecholamine levels, they were within normal limits ([Table 2(a)](#tab2){ref-type="table"}). In addition, computed tomography of the abdomen did not indicate the presence of a mass lesion, which suggests pheochromocytoma; therefore, we ruled out pheochromocytoma.

In our case, immediate replacement therapy with hydrocortisone sufficiently improved her cardiomyopathy. Therefore, we could conclude that her myocardial dysfunction was closely related to adrenal insufficiency. Six cases of reversible left ventricular dysfunction or cardiomyopathy associated with isolated ACTH deficiency have been reported previously \[[@B5]--[@B9]\]. Similar to these six cases, intensive stress induced by adrenal insufficiency caused reversible cardiomyopathy in our patient, although the detailed mechanism of left ventricular dysfunction in Takotsubo cardiomyopathy remains unknown \[[@B10]--[@B17]\]. According to the report by Ukita et al. \[[@B8]\], they listed all cases of Takotsubo cardiomyopathy with isolated ACTH deficiency \[[@B5]--[@B7]\]. Comparing those cases, we found that all cases including ours were female patients although we could not figure out the meanings of the sex difference. Furthermore, though patients with Takotsubo cardiomyopathy often feel chest pain, most of cases with isolated ACTH deficiency did not feel chest pain including ours. Interestingly, Gotyo et al. reported male patient developing Takotsubo cardiomyopathy with idiopathic ACTH deficiency\[[@B9]\]. Their patient also impaired GH secretion, and it was not isolated ACTH deficiency with regard to definition; therefore, they used the word idiopathic ACTH deficiency.

To our knowledge, this case represents the first report of both delirium and Takotsubo cardiomyopathy associated with isolated ACTH deficiency. In summary, the present case of a patient suffering from delirium and Takotsubo cardiomyopathy was subsequently diagnosed with adrenal insufficiency induced by isolated ACTH deficiency secondary to a diagnosis of hyponatremia. Both symptoms resolved immediately after the start of steroid replacement therapy with no subsequent relapse; therefore, the unstable mental status and cardiac dysfunction are considered to have been secondary to adrenal insufficiency. Therefore, patients with delirium or Takotsubo cardiomyopathy with no apparent etiology should be examined for adrenal function and begin immediate steroid replacement, if needed.

![Electrocardiogram changes on admission and four days later while suffering from cardiomyopathy. New inverted T waves were present in the V3-4 leads.](CRIM.ENDOCRINOLOGY2012-580481.001){#fig1}

![Left ventriculography ((a) systole, (b) diastole) demonstrates akinesis of the apex with systolic ballooning.](CRIM.ENDOCRINOLOGY2012-580481.002){#fig2}

###### 

Laboratory findings on admission.

  ----------------------------- -----------------------------
  Peripheral blood               
   White blood cells            4600/*μ*L (3300--9500)
    Neutrophils                 68.5% (37--80)
    Lymphocytes                 19.7% (11--50)
    Monocytes                   10.3% (4--11)
    Basophils                   0.2% (0--2)
    Eosinophils                 1.3% (0--8)
   Red blood cells              386 × 10^4^/*μ*L (389--501)
   Hemoglobin                   11.7 g/dL (11.3--15.2)
   Hematocrit                   30.2% (33.4--46.4)
   Platelet                     16.2 × 10^4^/*μ*L (14--36)
                                
  Serum chemistry                
   Sodium                       116 mEq/L (136--147)
   Potassium                    4.5 mEq/L (3.5--5.0)
   Chloride                     84 mEq/L (95--110)
   Glucose                      132 mg/dL (70--110)
   Urea nitrogen                6.4 mg/dL (7.0--22.0)
   Creatinine                   0.52 mg/dL (0.40--0.90)
   Uric acid                    3.1 mg/dL (0.0--7.0)
   Total protein                6.1 g/dL (6.3--8.5)
   Albumin                      3.8 g/dL (3.3--5.1)
   Aspartate aminotransferase   33 IU/L (10--38)
   Alanine aminotransferase     15 IU/L (6--38)
   Lactate dehydrogenase        211 IU/L (115--255)
   C-reactive protein           0.3 mg/dL (0.0--0.2)
  ----------------------------- -----------------------------

Figures in parentheses indicate the normal range.

###### 

Hormonal data in detailed examination.

###### 

\(a\) Basal levels

  ----------------------- ----------------------------
  ACTH                    8.4 pg/mL (7.2--63.3)
  Cortisol                2.2 *μ*g/dL (4.0--18.3)
  TSH                     1.52 *μ*IU/mL (0.55--4.78)
  FT3                     2.38 pg/mL (2.13--4.07)
  FT4                     1.89 ng/dL (0.89--1.76)
  Plasma renin activity   0.3 ng/mL/hr (0.3--2.9)
  Plasma aldosterone      76.8 pg/mL (29.9--159.0)
  Urine free cortisol     8.7 *μ*g/day (11.2--80.3)
  Urine metanephrine      0.03 mg/day (0.04--0.19)
  Urine normetanephrine   0.16 mg/day (0.09--0.33)
  ----------------------- ----------------------------

Figures in parentheses indicate the normal range.

###### 

\(b\) Rapid ACTH test

  Time (min)           0     30     60
  -------------------- ----- ------ ------
  Cortisol (*μ*g/dL)   5.4   14.1   16.8

###### 

\(c\) CRH, LHRH, GRH test

  Time (min)           0       30      60      90      120
  -------------------- ------- ------- ------- ------- -------
  ACTH (pg/mL)         7.8     14.3    11.7    9.2     8.3
  Cortisol (*μ*g/dL)   5.7     6.4     5.7     5.4     5.4
  LH (mIU/mL)          19.92   64.31   68.04   66.7    62.75
  FSH (mIU/mL)         64.50   75.37   79.86   82.44   86.36
  GH (ng/mL)           0.64    8.72    12.3    12.1    4.66

###### 

\(d\) Continuous ACTH test

  -------------------------------- ----- ----- ----- ------ ------- ------- --------
  Day                              1     2     3     4      5       6       7
                                                                            
  Urine free cortisol (*μ*g/day)   5.8   7.0   7.5   99.8   546.0   866.0   2950.0
  -------------------------------- ----- ----- ----- ------ ------- ------- --------

###### 

Reported cases with isolated ACTH deficiency with delirium.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case   Age/Sex   Past history           Preceding duration of physical symptoms   Mental symptoms                     Normalization of delirium   Steroid hormone therapy   Reference
  ------ --------- ---------------------- ----------------------------------------- ----------------------------------- --------------------------- ------------------------- --------------
  1      68/M      Stroke                 4 months                                  Disorientation to time and place\   1 day                       Cortisone acetate\        \[[@B2]\]
                                                                                    incontinence                                                    25 mg/d PO for 10 days\   
                                                                                                                                                    37.5 mg/d PO              

  2      74/M      ---                    1 week                                    Delirious state                     3 days                      Hydrocortisone\           \[[@B3]\]
                                                                                                                                                    Details unclear           

  3      67/M      Cholecystitis          7 weeks                                   Incoherent speech and conduct\      Details unclear             Hydrocortisone\           \[[@B4]\]
                                                                                    incontinence                                                    20 mg/d PO                

  4      65/F      Hashimoto\'s disease   1 week                                    Paranoia\                           3 days                      Hydrocortisone\           Present case
                                                                                    visual hallucinations                                           400 mg/d IV for 2 days\   
                                                                                                                                                    20 mg/d PO                
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PO: per os, IV: intravenously, and d: day.
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